Literature DB >> 31157585

Reorienting Health Services to People with Chronic Health Conditions: Diabetes and Stroke Services in Malaysia, Sri Lanka and Thailand.

Vasoontara Yiengprugsawan1,2, Judith Healy3, Hal Kendig1,2, Malinee Neelamegam4, Palitha Karunapema5, Vijj Kasemsup6.   

Abstract

This paper explores whether middle-income Asian countries are reorienting their health services in response to non-communicable diseases (NCDs). Malaysia, Sri Lanka, and Thailand were selected as case studies of Asian societies experiencing rapid increases both in NCDs and an aging population. While NCD programs, especially those related to diabetes and stroke, are well-established in Thailand, health services struggle to respond to increasing numbers of people with chronic health problems. Health services at all levels must plan ahead for more patients with chronic and often multiple conditions who require better integrated health care.

Entities:  

Keywords:  Middle-income Asian countries; NCDs; diabetes; elderly patients; health services; non-communicable disease; primary health care; stroke

Year:  2017        PMID: 31157585     DOI: 10.1080/23288604.2017.1356428

Source DB:  PubMed          Journal:  Health Syst Reform        ISSN: 2328-8620


  2 in total

1.  Disparities in outpatient and inpatient utilization by rural-urban areas among older Mongolians based on a modified WHO-SAGE instrument.

Authors:  Vasoontara Sbirakos Yiengprugsawan; Gantuya Dorj; Jocelyn G Dracakis; Bilegt Batkhorol; Undram Lkhagvaa; Dulamsuren Battsengel; Chimedsuren Ochir; Nirmala Naidoo; Paul Kowal; Robert G Cumming
Journal:  BMC Health Serv Res       Date:  2021-10-30       Impact factor: 2.655

2.  Coverage and equity of essential care services among stroke survivors in the Western Province of Sri Lanka: a community-based cross-sectional study.

Authors:  Nalinda Tharanga Wellappuli; Hettiarachchige Subashini Rasanja Perera; Thashi Chang; Gunendrika Kasthuriratne; Nalika Sepali Gunawardena
Journal:  BMC Health Serv Res       Date:  2022-08-10       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.